Medicis Pharmaceutical (MRX +2.3%) gains after saying it's completed its acquisition of bankrupt...

|By:, SA News Editor

Medicis Pharmaceutical (MRX +2.3%) gains after saying it's completed its acquisition of bankrupt Canadian drug maker Graceway Pharmaceuticals. Through the purchase Medicis gains access to Graceway's strong R&D pipeline, including several patented and patent-pending mid-to-late stage assets, with an annual net sales peak potential of over $500M.